Andres McAllister
Hoofd Techniek/Wetenschap/O&O bij BIOINVENT INTERNATIONAL AB
Vermogen: 7 128 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Andres McAllister
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 30 | |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andres McAllister via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member Director/Board Member | |
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Chairman | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree | |
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| University of Cambridge | College/University | Masters Business Admin | |
| CELLAVISION AB | Medical Specialties | Director/Board Member | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin | |
| University of Michigan | College/University | Masters Business Admin | |
| Stockholm School of Economics | College/University | Masters Business Admin | |
| University College Dublin | College/University | Undergraduate Degree | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
Envirotainer AB
 Envirotainer AB Containers/PackagingProcess Industries Envirotainer AB provides cold chain solutions for the pharmaceutical supply chain. It offers active cold chain services, qualification services, shipment set up services, technical support, post-shipment analysis and telemetry solution. The company was founded in 1985 and is headquartered in Sollentuna, Sweden. | Containers/Packaging | Chief Executive Officer | |
| The State University of New York | College/University | Corporate Officer/Principal | |
| University College London | College/University | Doctorate Degree | |
| University of Lund | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| Erasmus University Rotterdam | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal | |
| Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
Bure Equity (Private Equity)
 Bure Equity (Private Equity) Investment ManagersFinance Bure Equity AB Private Equity (BEPE) is the private equity investment division of the Swedish firm, Bure Equity AB (ST: BURE). In 1992, the firm was founded as Bure Förvaltnings AB. In 2000, the firm changed their name to Bure Equity AB and decided to focus entirely on private equity investments. BEPE specializes in long-term ownership of unlisted firms. They operate from offices in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Apposite Capital LLP
 Apposite Capital LLP Investment ManagersFinance Apposite Capital LLP (Apposite Capital) is a private equity arm of Mizuho Financial Group, Inc. founded in 2016 by David Porter. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
| ONCODESIGN | Biotechnology | Director/Board Member | |
| University of Gothenburg | College/University | Undergraduate Degree | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chairman | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Director of Investments | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chairman | |
| Pfizer AB | Chief Executive Officer | ||
Stockholm Chamber of Commerce
 Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Qbtech AB
 Qbtech AB Information Technology ServicesTechnology Services Qbtech AB is a company that specializes in ADHD and related conditions. The company is based in Stockholm, Sweden and was founded in 2002. The Swedish company is backed by over 35 pieces of research and offer clinical research related to their products. The CEO is Carl Reuterskiöld. | Information Technology Services | Chief Executive Officer | |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member | |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member Chief Executive Officer | |
Egain Sweden AB
 Egain Sweden AB Miscellaneous Commercial ServicesCommercial Services eGain Sweden AB provides energy and environmental optimization service. It offers EGain forecasting, a service that is constantly further developed and the latest news with the self-learning optimization, which means that the system is self-optimizing and adjusting the indoor climate at the right levels. The company was founded by Anders Thorbjorn Geiser in 2003 and is headquartered in Kungsbacka, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
MD International AB
 MD International AB Medical/Nursing ServicesHealth Services MD International AB provides digital healthcare services. It operates an online platform for patients with disabilities and sickness. The company was founded by Lars Magnus Nyhlen in 2013 and is headquartered in Malmö, Sweden. | Medical/Nursing Services | Chairman | |
CCP Investment Partners AB
 CCP Investment Partners AB Investment ManagersFinance CCP Investment Partners AB (Ceder Capital) is a private equity firm headquartered in Stockholm, Sweden. The firm was founded in 2014. | Investment Managers | Founder | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Adero AB
 Adero AB Engineering & ConstructionIndustrial Services Part of Storskogen Group AB, Adero AB is a company that provides heating, ventilation, air conditioning, and building installation services. The company is based in Stockholm, Sweden. Adero was acquired by Storskogen Group AB on October 11, 2021. Andreas Benetoft has been the CEO of the Swedish company since 2013. | Engineering & Construction | Director/Board Member | |
| ONCODESIGN PRECISION MEDICINE | Pharmaceuticals: Major | Director/Board Member | |
Affinicon ApS
 Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Zweden | 21 |
| Denemarken | 7 |
| Verenigd Koninkrijk | 6 |
| Verenigde Staten | 6 |
| Nederland | 5 |
Sectoraal
| Health Technology | 19 |
| Consumer Services | 15 |
| Finance | 6 |
| Commercial Services | 5 |
| Health Services | 4 |
Operationeel
| Director/Board Member | 191 |
| Independent Dir/Board Member | 48 |
| Corporate Officer/Principal | 45 |
| Chairman | 44 |
| Chief Executive Officer | 33 |
Sterkste connecties
- Beurs
- Insiders
- Andres McAllister
- Bedrijfsconnecties
